Citation: Jw. Steinke et L. Borish, Th2 cytokines and asthma interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists, RESPIR RES, 2(2), 2001, pp. 66-70
Citation: M. Mardiney et L. Borish, Aspirin desensitization for chronic hyperplastic sinusitis, nasal polyposis, and asthma triad, ARCH OTOLAR, 127(10), 2001, pp. 1287-1287
Authors:
Makela, MJ
Kanehiro, A
Borish, L
Dakhama, A
Loader, J
Joetham, A
Xing, Z
Jordana, M
Larsen, GL
Gelfand, EW
Citation: Mj. Makela et al., IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization, P NAS US, 97(11), 2000, pp. 6007-6012
Authors:
Burchard, EG
Silverman, EK
Rosenwasser, LJ
Borish, L
Yandava, C
Pillari, A
Weiss, ST
Hasday, J
Lilly, CM
Ford, JG
Drazen, JM
Citation: Eg. Burchard et al., Association between a sequence variant in the IL-4 gene promoter and FEV1 in asthma, AM J R CRIT, 160(3), 1999, pp. 919-922
Authors:
Hobbs, K
Negri, J
Klinnert, M
Rosenwasser, LJ
Borish, L
Citation: K. Hobbs et al., Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma, AM J R CRIT, 158(6), 1998, pp. 1958-1962